SALA DE PRENSA



  • Visual inspection of by-pass syringes

    Sanofi completes the acquisition of Protein Sciences

    - An innovative quadrivalent influenza vaccine will complement Sanofi Pasteur vaccine portfolio -

     

    Paris, France - August 28, 2017 - Sanofi announced today that it has completed the acquisition of Protein Sciences, a vaccines biotechnology company based in Meriden, Connecticut in the United States. This completion follows Federal Trade Commission approval, having met all the conditions required for the closing of the transaction.

    - 08/28/2017